The Olleyes VisuALL could alleviate limitations in testing pediatric patients and make visual field testing more accessible, cost-effective, and convenient for patients and clinicians.
Read Press ReleaseRegulatory approval brings latest tech to Latin America. Olleyes' VR testing platform increases access to care and increases office efficiency for eye care physicians.
Read Press ReleaseStudy completed at Duke University shows that the VisuALL is suitable substitute for HVF when testing pediatric patients.
Read Press ReleaseDr. Dan B. Tran, Founder and Medical Director at Coastal Vision Medical Group, is the first surgeon in Southern California's Orange County and Inland Empire regions to offer custom laser cataract surgery using the ALLY® Adaptive Cataract Treatment System.
Read Press ReleaseIn the Digital Health and Startups category at the 2023 Consumer Electronics Show (CES), Eyenovia showcased its Microdose Array Print (MAP™) Technology, the first significant advancement in ocular drug delivery methods in over a century.
Read Press Release•• Complete epithelial recovery was achieved by 67% of subjects receiving NEXAGON, as opposed to 27% receiving Vehicle alone
•• NEXAGON was well-tolerated demonstrating a safety profile similar to vehicle
•• Amber plans to initiate the NEXPEDE-1 Phase 2/3 clinical trial in subjects with PCED of various etiologies in Q1 2023 ••
The Microdose Array Print (MAP) Technology has shown potential in clinical trials, providing the possibility of more accurate ocular drug delivery than traditional eye droppers
Read Press ReleaseFDA 510 (K) clearance was based on a pivotal clinical trial evaluating the safety and effectiveness of this novel eye-tracking-based amblyopia therapy vs eye patching, the gold standard.
Read Press ReleaseLeading Ophthalmology Practice, Coastal Vision Medical Group Among First to Offer EVO Visian ICL in Southern California to Provide Visual Freedom from Glasses and Contact Lenses
Read Press ReleaseThe newly approved connected device will facilitate patient access and communication between patients and eye care providers, collect data, and provide a platform between home and office to optimize treatment for dry eye
Read Press ReleaseThe in-vitro studies performed in Glauconix's co-culture 3D conventional human outflow model confirm efficacy
Read Press Release3D Human Tissue Retina Vasculature model provides a new and novel approach to rapidly and efficiently screening numerous therapies for diabetic retinopathy and diabetic macular edema.
Read Press ReleaseAppointment reflects Glauconix Biosciences' expansion of their 3D Human Tissue model platform within the Ophthalmology space and brings their second commercial model closer to market
Read Press Release